Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain
CompletedNot applicableNCT02450604
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Fabry disease is a rare inherited metabolic disorder that predominantly affects heart, kidneys and nervous system. Fabry disease has been searched in series of patients presenting different isolated signs caused by the affection of one of these organs. Acroparesthesias and chronic crises of pain of different origins are reported in the large majority of patients during the progression of the disease. Moreover, this signs are frequently inaugurating the disease. The investigators have previously performed a preliminary single-center study which permitted to identify one female patient with Fabry disease in a series of 147 consecutive patients with chronic pain tested. The investigators now propose to confirm the results of our preliminary study. The investigators plan to evaluate the prevalence of Fabry disease in a series of 1000 patients suffering from chronic pains of undetermined aetiology and consecutively recruited.
Study details
- Official title
- Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain
- Conditions
- Fabry's Disease
- Chronic Pain
- Interventions
- Genetic: Diagnosis of Fabry disease
- Sponsor
- University Hospital, Bordeaux
- Start date
- 2015-03-05
- Primary completion
- 2021-12-15
- Sex
- All
- Age range
- from 6 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 21
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients of both sex, * aged from 6 to 80, * with chronic pains of unknown aetiology including: acroparesthesias, and/or pain crises evolving more than 3 months, continued neuropathic evolving more than 3 months, and/or multiple pains evolving more than 3 months and/or recurrent abdominal crises of pain who come for a clinical visit in the pain Centres of France. Exclusion Criteria: * chronic pain of known cause
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02450604